Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oruka Therapeutics, Inc. - Common Stock
(NQ:
ORKA
)
29.76
+0.95 (+3.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
177,185
Open
29.71
Bid (Size)
29.71 (3)
Ask (Size)
29.76 (16)
Prev. Close
28.81
Today's Range
28.55 - 30.45
52wk Range
22.51 - 31.13
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
October 08, 2024
Via
Benzinga
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
September 25, 2024
From
Oruka Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
+16.71%
+16.71%
1 Month
+19.90%
+19.90%
3 Month
+16.71%
+16.71%
6 Month
+16.71%
+16.71%
1 Year
+16.71%
+16.71%
More News
Read More
Oruka Therapeutics Announces $200 Million Private Placement
September 12, 2024
From
Oruka Therapeutics, Inc.
Via
GlobeNewswire
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
September 12, 2024
From
Oruka Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.